Pharma Mar, S.A. (BME:PHM)

Spain · Delayed Price · Currency is EUR

70.30

+0.65 (0.93%)

Oct 6, 2026, 5:38 PM CET

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Oncology	221.35M	174.59M	156.84M	191.18M	224.67M
RNA Interference (RNAi)	36.00K	262.00K	121.00K	31.00K	3.00K
Unallocated Parent company expenses	-	-	1.19M	-	-
Others	-	-	-	5.13M	5.16M
Total	221.39M	174.86M	158.15M	196.34M	229.83M

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Spain	2.48M	3.90M	6.93M	16.64M	17.35M
Ireland	100.62M	78.94M	75.36M	86.79M	110.00M
Germany	27.13M	4.88M	4.64M	14.98M	18.21M
France	24.24M	22.13M	30.00M	17.39M	-
United States	20.13M	22.41M	12.51M	13.37M	2.31M
Switzerland	6.42M	-	-	-	-
Rest of EU	12.26M	12.06M	10.90M	18.92M	53.32M
Others	28.12M	24.82M	13.63M	13.09M	11.48M
China	-	5.72M	-	-	-
Italy	-	-	4.19M	15.17M	17.15M
Total	221.39M	174.86M	158.15M	196.34M	229.83M